• AMAG Pharmaceuticals Inc., of Lexington, Mass., reported total revenues for the third quarter of $17.7 million, falling short of analyst estimates of $20.4 million. Revenue included $16.2 million in net U.S. sales for iron deficiency product Feraheme (fermuoxytol), which increased over the second quarter of 2012 due to improved pricing dynamics.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter